Read More Pharma Industry News Technology News Does BioHive-2 redefine capital efficiency for Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)? Can BioHive-2 accelerate Recursion Pharmaceuticals’ pipeline and justify its AI infrastructure bet? Explore the strategic stakes for NASDAQ: RXRX. bySoujanya RaviFebruary 25, 2026